InvestorsHub Logo
Followers 4
Posts 156
Boards Moderated 0
Alias Born 05/11/2020

Re: None

Saturday, 08/08/2020 7:20:25 AM

Saturday, August 08, 2020 7:20:25 AM

Post# of 16707
"The drug, which was tested on a coronavirus patient overseas for the first time Wednesday, may reduce the severity and duration of COVID-19 infections, according to Algernon Pharmaceuticals, a Canadian drug repurposing company that investigates pre-approved drugs for new disease applications and is now leading Ifenprodil’s COVID-19 testing."

Overseas.. Hmmm..

Just looking at the results of the research, it’s astonishing,” said Mark Williams, Algernon’s medical director.

Mark Williams is why I keep my money here.

https://www.miamiherald.com/news/local/community/miami-dade/article244809382.html

B. O. B.